– Gilead to License Exclusive Worldwide Rights to the Investigational Candidate DF7001, a 5T4-Targeting NK Cell Engager for Solid Tumors –
– Gilead to Have Options to License Several Additional NK Cell
Itron, Inc. (NASDAQ:ITRI), which is innovating the way utilities and cities manage energy and water, and Duke Energy Florida, which supplies electrical services to 1.9 million customers throughout Florida, are